Recalcitrant pyoderma gangrenosum treated with thalidomide

被引：44
|
作者：
Federman, GL
Federman, DG
机构：
[1] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA
[2] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA
来源：
MAYO CLINIC PROCEEDINGS | 2000年 / 75卷 / 08期
关键词：
D O I：
10.4065/75.8.842
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Pyoderma gangrenosum is a painful, noninfectious, ulcerating skin disorder often associated with systemic disease. Thalidomide has been used to treat many inflammatory dermatologic conditions and has been reintroduced in the United States to treat immune-modulated diseases such as pyoderma gangrenosum. The patient described, a 47-year-old man, had histologically confirmed pyoderma gangrenosum that did not respond to treatment with several courses of methylprednisolone. The ulcer healed with 10 weeks of oral thalidomide administration.
引用
收藏
页码：842 / 844
页数：3
相关论文
共 50 条
  • [41] Pyoderma gangrenosum successfully treated with Cyclosporin A
    V'lckova-Laskoska, MT
    Laskoski, DS
    Caca-Biljanovska, NG
    Darkoska, JS
    RHEUMADERM: CURRENT ISSUES IN RHEUMATOLOGY AND DERMATOLOGY, 1999, 455 : 541 - 545
  • [42] Pyoderma gangrenosum of the scalp treated with cyclosporine A
    Patrone, P
    Bragadin, G
    De Francesco, V
    Frattasio, A
    Stinco, G
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2002, 41 (12) : 916 - 918
  • [43] TREATMENT OF PYODERMA GANGRENOSUM WITH THALIDOMIDE IN MYELODYSPLASTIC SYNDROME: A CASE REPORT
    Malkan, Umit Yavuz
    Gunes, Gursel
    Yayar, Okan
    Aslan, Tuncay
    Aksu, Salih
    Haznedaroglu, Ibrahim Celalettin
    LEUKEMIA RESEARCH, 2015, 39 : SS39 - SS39
  • [44] PYODERMA GANGRENOSUM TREATED WITH CYCLOSPORIN-A
    CURLEY, RK
    MACFARLANE, AW
    VICKERS, CFH
    BRITISH JOURNAL OF DERMATOLOGY, 1985, 113 (05) : 601 - 604
  • [45] Paediatric pyoderma gangrenosum treated with ustekinumab
    Savasta, Emanuele
    Coppo, Paola
    La Selva, Roberta
    Opramolla, Anna
    Pinon, Michele
    JEADV CLINICAL PRACTICE, 2024, 3 (03): : 895 - 897
  • [46] Chlorambucil is an effective corticosteroid-sparing agent for recalcitrant pyoderma gangrenosum
    Burruss, JB
    Farmer, ER
    Callen, JP
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1996, 35 (05) : 720 - 724
  • [47] Recalcitrant Ulcerative Pyoderma Gangrenosum of the Leg Responsive to Tildrakizumab: A Case Report
    Leow, Liang Joo
    Zubrzycki, Nicolas
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2022, 15 : 1729 - 1736
  • [48] Polyneuropathy developing after infliximab therapy in a patient with recalcitrant pyoderma gangrenosum
    Singer, Ralfi
    Orken, Cihat
    Gungor, Sule
    Copur, Mehmet
    Kiziltac, Utkan
    Kiziltac, Kubra
    Goncu, Emek Kocaturk
    Erhan, Selma Sengiz
    TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2019, 53 (01): : 24 - 27
  • [49] EFFICACY OF FK-506 IN THE TREATMENT OF RECALCITRANT PYODERMA-GANGRENOSUM
    ABUELMAGD, K
    JEGASOTHY, BV
    ACKERMAN, CD
    THOMSON, AW
    RILO, H
    NIKOLAIDIS, N
    VANTHIEL, D
    FUNG, JJ
    TODO, S
    STARZL, TE
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (06) : 3328 - 3329
  • [50] Novel combination of intravenous immunoglobulin and rituximab in the treatment of recalcitrant pyoderma gangrenosum
    Bennett, M.
    McAleer, M. A.
    Murphy, M.
    Harney, S.
    Bourke, J. F.
    BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 : 35 - 35
12345